Ferrostatin-1 protects against necrotizing enterocolitis intestinal injury by inhibiting ferroptosis
Pediatric Surgery International · 2025
DOI: 10.1007/s00383-025-06240-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Surgery International, 2025. Verfasst von Chen-Yi Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Surgery, Shengjing Hospital of China Medical University, Shenyang, China. Hauptthemen laut MEDLINE: Ferroptosis, Enterocolitis, Necrotizing, Cyclohexylamines, Phenylenediamines. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: China Scholarship Council, CIHR, Canadian Institutes of Health Research.
Abstract (Originalsprache)
PURPOSE: Necrotizing enterocolitis (NEC) is a severe neonatal disease marked by intestinal injury, and epithelial damage has been linked to ferroptosis. This study aimed to determine the protective effect of Ferrostatin-1 (Fer-1), a ferroptosis inhibitor, on NEC-associated intestinal injury. METHODS: NEC was induced in mouse pups via formula feeding, hypoxia, and lipopolysaccharide exposure. Fer-1 (5 mg/kg) was administered intraperitoneally on postnatal days 6 and 8. Intestinal tissues were analyzed for morphological injury, epithelial proliferation (Ki67), ferroptosis markers (Gpx4 and Tfr1), and lipid peroxidation (4-HNE). Human NEC intestinal organoids derived from surgical samples were treated with Fer-1 (2 µM) for 48 h. Levels of ferrous ion (FerroOrange), lipid peroxide (BODIPY), and reactive oxygen species (DCFDA) were measured. RESULTS: Fer-1 significantly reduced NEC-induced epithelial injury in mice, leading to improved intestinal morphology and increased epithelial proliferation, as indicated by elevated Ki67 expression. The protective effect was associated with reduced ferroptosis, demonstrated by upregulated Gpx4 expression and decreased levels of Tfr1 and 4-HNE. Similarly, in human NEC organoids, Fer-1 significantly reduced the accumulation of ferrous ions, lipid peroxides, and ROS. CONCLUSION: Fer-1 effectively protects against NEC-induced intestinal injury by inhibiting ferroptosis and reducing oxidative stress. These findings highlight its potential as a novel therapeutic strategy for managing intestinal damage in NEC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatric Surgery, Shengjing Hospital of China Medical University, Shenyang, China.
- Translational Medicine Program, Division of General and Thoracic Surgery, Department of Translational Medicine, Hospital for Sick Children, University of Toronto, 555 University Avenue, Toronto, ON, M5G 1X8, Canada.
- Translational Medicine Program, Division of General and Thoracic Surgery, Department of Translational Medicine, Hospital for Sick Children, University of Toronto, 555 University Avenue, Toronto, ON, M5G 1X8, Canada. ago…
Förderung
- China Scholarship Council
- CIHR
- Canadian Institutes of Health Research
Zitieren
APA
Wang, C. Y., Feizi, M., Li, B., Lee, C., Lee, D., Yang, J., Kang, Y., Bai, Y. Z., & Pierro, A. (2025). Ferrostatin-1 protects against necrotizing enterocolitis intestinal injury by inhibiting ferroptosis. Pediatric Surgery International. https://doi.org/10.1007/s00383-025-06240-2
Vancouver
Wang CY, Feizi M, Li B, Lee C, Lee D, Yang J, et al. Ferrostatin-1 protects against necrotizing enterocolitis intestinal injury by inhibiting ferroptosis. Pediatric Surgery International. 2025. doi:10.1007/s00383-025-06240-2
BibTeX
@article{Wang2025,
author = {Wang, Chen-Yi and Feizi, Mehrsa and Li, Bo and Lee, Carol and Lee, Dorothy and Yang, Jielin and Kang, Ying and Bai, Yu-Zuo and Pierro, Agostino},
title = {Ferrostatin-1 protects against necrotizing enterocolitis intestinal injury by inhibiting ferroptosis},
journal = {Pediatric Surgery International},
year = {2025},
doi = {10.1007/s00383-025-06240-2}
}
EUVIMED